Investment Analysts at Barclays upgraded Seattle Genetics Inc. (NASDAQ:SGEN) shares from Equal Weight to Overweight rating while increasing their price target from $60 to $70.
Seattle Genetics, Inc. engages in the development and commercialization of monoclonal antibody-based therapies for cancer.
Brokerage Firm Argus upgraded Harley-Davidson Inc. (NYSE:HOG) shares from Hold to Buy rating with a price target of $53.
Harley-Davidson, Inc. manufactures and sells heavyweight motorcycles as well as a line of motorcycle parts, accessories, general merchandise and related services.
Resolute Energy Corp. (NYSE:REN) shares were upgraded by analysts at Goldman from Neutral to Buy rating.
Resolute Energy Corp. engages in the acquisition, development and production of onshore domestic hydrocarbons, principally crude oil.
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/